| Product NDC: | 0591-0800 |
| Proprietary Name: | Hydroxyzine Pamoate |
| Non Proprietary Name: | Hydroxyzine Pamoate |
| Active Ingredient(s): | 25 mg/1 & nbsp; Hydroxyzine Pamoate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0591-0800 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040156 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19960715 |
| Package NDC: | 0591-0800-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE, PLASTIC (0591-0800-05) |
| NDC Code | 0591-0800-05 |
| Proprietary Name | Hydroxyzine Pamoate |
| Package Description | 500 CAPSULE in 1 BOTTLE, PLASTIC (0591-0800-05) |
| Product NDC | 0591-0800 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydroxyzine Pamoate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19960715 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | HYDROXYZINE PAMOATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |